Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BLZ945 |
Trade Name | |
Synonyms | BLZ-945|BLZ 945 |
Drug Descriptions |
BLZ945 is a selective inhibitor of CSF1R, which potentially leads to a decrease in tumor associated macrophages (PMID: 24498562, PMID: 29930294). |
DrugClasses | CSF1R Inhibitor 28 |
CAS Registry Number | 953769-46-5 |
NCIT ID | C129653 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BLZ945 | BLZ945 | 2 | 1 |
BLZ945 + Buparlisib | BLZ945 Buparlisib | 0 | 0 |
BLZ945 + Linsitinib | BLZ945 Linsitinib | 0 | 0 |
BLZ945 + Osimertinib | BLZ945 Osimertinib | 0 | 0 |
BLZ945 + Spartalizumab | BLZ945 Spartalizumab | 0 | 1 |